Seven Eight Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-59,628
Closed -$6.17M 633
2021
Q4
$6.17M Buy
+59,628
New +$6.9M 1.1% 10
2020
Q2
Sell
-15,300
Closed -$1.38M 482
2020
Q1
$1.38M Sell
15,300
-17,032
-53% -$1.81M 0.35% 78
2019
Q4
$3.67M Sell
32,332
-26,200
-45% -$2.87M 0.19% 160
2019
Q3
$6.36M Sell
58,532
-17,909
-23% -$1.87M 0.34% 84
2019
Q2
$7.45M Sell
76,441
-135,700
-64% -$12.4M 0.39% 69
2019
Q1
$19.3M Buy
+212,141
New +$19M 1.02% 3
2018
Q4
Sell
-83,641
Closed -$8.23M 642
2018
Q3
$8.23M Buy
+83,641
New +$7.73M 0.5% 46
2017
Q4
Sell
-18,241
Closed -$1.42M 527
2017
Q3
$1.42M Buy
18,241
+18,200
+44,390% +$1.51M 0.17% 192
2017
Q2
$4K Sell
41
-58,300
-100% -$4.92M ﹤0.01% 535
2017
Q1
$4.7M Buy
58,341
+15,900
+37% +$1.24M 0.91% 16
2016
Q4
$3.02M Buy
+42,441
New +$3.33M 0.61% 27
2016
Q2
Sell
-23,277
Closed -$1.75M 614
2016
Q1
$1.75M Buy
23,277
+20,400
+709% +$1.54M 0.74% 19
2015
Q4
$221K Buy
+2,877
New +$217K 0.15% 222
2015
Q3
Sell
-577
Closed -$43K 624
2015
Q2
$43K Buy
+577
New +$44.1K 0.05% 353
2015
Q1
Sell
-8,300
Closed -$599K 608
2014
Q4
$599K Sell
8,300
-12,100
-59% -$841K 1% 8
2014
Q3
$1.26M Buy
20,400
+20,000
+5,000% +$1.27M 0.96% 13
2014
Q2
$25K Buy
+400
New +$24.3K 0.02% 428

Other funds holding MDT

Seven Eight Capital's MDT Position: Q1 2022 in Review

Seven Eight Capital sold out of Medtronic (MDT) in Q1 2022, closing a stake of 59,628 shares — an estimated $6.17M sold.

Seven Eight Capital first reported a position in MDT in Q2 2014 and held it in 17 quarters. The position peaked at $19.3M in Q1 2019. 2,102 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Seven Eight Capital reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Seven Eight Capital sold 59,628 Medtronic shares in Q1 2022, an estimated $6.17M.
  • Seven Eight Capital first reported a position in Medtronic in Q2 2014 and held it in 17 quarters.
  • Seven Eight Capital's Medtronic position peaked at $19.3M in Q1 2019.
  • 2,102 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Seven Eight Capital's 13F filing for Q1 2022, filed 11 May 2022.